Treatment of Pleural Tuberculosis in Children and Adolescents Aged 3 Months to 16 Years
Uncomplicated tuberculous pleural effusion in children and adolescents aged 3 months to 16 years — presenting without pneumothorax or empyema and classified as non-severe TB — has a clearly defined first-line treatment approach in current international guidelines.
Clinical Scenario
This protocol applies to paediatric patients aged between 3 months and 16 years with uncomplicated tuberculous pleural effusion: effusion without pneumothorax or empyema, representing a non-severe form of tuberculosis. The age range and absence of complications are the defining features that determine regimen selection.
Treatment Approach
A 4-month short-course combination anti-tuberculosis regimen is recommended for this age group. Whether an additional agent is incorporated during the initial phase depends on specific epidemiological and clinical considerations. Full regimen details, phase structure, and decision criteria are available in the complete protocol below.
Treatment Goals
TB symptoms are expected to resolve within one month of starting treatment. By the completion of the 4-month course, the child or adolescent should be completely well, with a normal nutritional status consistent with their baseline before the onset of TB symptoms.
References
- In children and adolescents aged between 3 months and 16 years with non-severe TB (without suspicion or evidence of MDR/RR-TB), a 4-month treatment regimen (2HRZ(E)/2HR) should be used.
- In cases of non-severe TB, the 4-month 2HRZ(E)/2HR regimen can be used for children and adolescents with peripheral lymph node TB, intrathoracic lymph node TB without airway obstruction and uncomplicated TB pleural effusion.
- Uncomplicated pleural effusion (without pneumothorax or empyema).
- Children and adolescents aged between 3 months and 16 years with non-severe DS-TB should receive the 4-month regimen 2HRZ(E)/2HR, which comprises isoniazid, rifampicin and pyrazinamide, with or without ethambutol, for 2 months followed by isoniazid and rifampicin for 2 months.
- In addition, it is recommended that ethambutol be added to the 4-month regimen for the first 2 months in settings with a high background prevalence of isoniazid resistance or HIV infection.
- TB symptoms are expected to have resolved within one month of treatment initiation.
- The child or adolescent is expected to be completely well, including a normal nutritional status (similar to before they developed symptoms of TB) after 4 months of treatment.